These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17378723)

  • 1. Genotypes, obesity and type 2 diabetes--can genetic information motivate weight loss? A review.
    Gable D; Sanderson SC; Humphries SE
    Clin Chem Lab Med; 2007; 45(3):301-8. PubMed ID: 17378723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation of the adenylyl cyclase 3 (AC3) locus and its influence on type 2 diabetes and obesity susceptibility in Swedish men.
    Nordman S; Abulaiti A; Hilding A; Långberg EC; Humphreys K; Ostenson CG; Efendic S; Gu HF
    Int J Obes (Lond); 2008 Mar; 32(3):407-12. PubMed ID: 17895882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifestyle and genetics in obesity and type 2 diabetes.
    Temelkova-Kurktschiev T; Stefanov T
    Exp Clin Endocrinol Diabetes; 2012 Jan; 120(1):1-6. PubMed ID: 21915815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic architecture of type 2 diabetes.
    Hara K; Shojima N; Hosoe J; Kadowaki T
    Biochem Biophys Res Commun; 2014 Sep; 452(2):213-20. PubMed ID: 25111817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nonsense polymorphism (R392X) in TLR5 protects from obesity but predisposes to diabetes.
    Al-Daghri NM; Clerici M; Al-Attas O; Forni D; Alokail MS; Alkharfy KM; Sabico S; Mohammed AK; Cagliani R; Sironi M
    J Immunol; 2013 Apr; 190(7):3716-20. PubMed ID: 23455496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spotlight on epigenetics as a missing link between obesity and type 2 diabetes.
    Dobosz AM; Dziewulska A; Dobrzyń A
    Postepy Biochem; 2018 Oct; 64(2):157-165. PubMed ID: 30656898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Genetics of Obesity and Type 2 Diabetes Mellitus: Past, Present, and Future.
    Ingelsson E; McCarthy MI
    Circ Genom Precis Med; 2018 Jun; 11(6):e002090. PubMed ID: 29899044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An explained variance-based genetic risk score associated with gestational diabetes antecedent and with progression to pre-diabetes and type 2 diabetes: a cohort study.
    Cormier H; Vigneault J; Garneau V; Tchernof A; Vohl MC; Weisnagel SJ; Robitaille J
    BJOG; 2015 Feb; 122(3):411-9. PubMed ID: 25041170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation at diabetes- and obesity-associated Loci may mirror neutral patterns of human population diversity and diabetes prevalence in India.
    Raj SM; Halebeedu P; Kadandale JS; Mirazon Lahr M; Gallego Romero I; Yadhav JR; Iliescu M; Rai N; Crivellaro F; Chaubey G; Villems R; Thangaraj K; Muniyappa K; Chandra HS; Kivisild T
    Ann Hum Genet; 2013 Sep; 77(5):392-408. PubMed ID: 23808542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of obesity and lifestyle interventions in the prevention and management of type 2 diabetes.
    Davis N; Forges B; Wylie-Rosett J
    Minerva Med; 2009 Jun; 100(3):221-8. PubMed ID: 19571786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics: spotlight on type 2 diabetes and obesity.
    Desiderio A; Spinelli R; Ciccarelli M; Nigro C; Miele C; Beguinot F; Raciti GA
    J Endocrinol Invest; 2016 Oct; 39(10):1095-103. PubMed ID: 27180180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic dissection of type 2 diabetes.
    Ridderstråle M; Groop L
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):10-7. PubMed ID: 19000735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of genetic variation in the cannabinoid receptor gene (CNR1) (G1359A polymorphism) on weight loss and cardiovascular risk factors after liraglutide treatment in obese patients with diabetes mellitus type 2.
    de Luis DA; Ovalle HF; Soto GD; Izaola O; de la Fuente B; Romero E
    J Investig Med; 2014 Feb; 62(2):324-7. PubMed ID: 24322329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of success to weight-loss intervention program in individuals at high risk for type 2 diabetes.
    Kong W; Langlois MF; Kamga-Ngandé C; Gagnon C; Brown C; Baillargeon JP
    Diabetes Res Clin Pract; 2010 Nov; 90(2):147-53. PubMed ID: 20655608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-diet interaction in relation to the prevention of obesity and type 2 diabetes: evidence from the Finnish Diabetes Prevention Study.
    Uusitupa M
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):225-33. PubMed ID: 15955472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forecasting Tunisian type 2 diabetes prevalence to 2027: validation of a simple model.
    Saidi O; O'Flaherty M; Mansour NB; Aissi W; Lassoued O; Capewell S; Critchley JA; Malouche D; Romdhane HB;
    BMC Public Health; 2015 Feb; 15():104. PubMed ID: 25885910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does weight loss prognosis depend on genetic make-up?
    Moreno-Aliaga MJ; Santos JL; Marti A; Martínez JA
    Obes Rev; 2005 May; 6(2):155-68. PubMed ID: 15836466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can reducing peaks prevent type 2 diabetes: implication from recent diabetes prevention trials.
    Haffner SM
    Int J Clin Pract Suppl; 2002 Jul; (129):33-9. PubMed ID: 12166604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCF7L2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer.
    Drake I; Wallström P; Hindy G; Ericson U; Gullberg B; Bjartell A; Sonestedt E; Orho-Melander M; Wirfält E
    Prostate; 2014 Sep; 74(12):1161-70. PubMed ID: 24961829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized Medication.
    Hu C; Jia W
    Diabetes; 2018 Jan; 67(1):3-11. PubMed ID: 29263166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.